Experience & Background
Erin is a director with the Life Sciences and Health Care Ecosystem research team where she focuses on the medical device and pharmaceutical industries. Erin’s work enables industry leaders to form valuable and lasting provider partnerships that will ultimately lead to an efficient, highly reliable health care delivery system.
Erin joined this team in 2020 after focusing on strategic planning and operational best practices for provider service lines leaders and independent provider executives. She authored and presented research on topics including ambulatory growth, imaging quality, and patient throughput. Prior to joining Advisory Board in 2013, Erin studied the prevalence of the bacterium resulting in Lyme disease at the University of Richmond, where she received her BS in Biochemistry and Molecular Biology.